Effects of intravenous immunoglobulin on alpha synuclein aggregation and neurotoxicity
Int Immunopharmacol; 2012 Sep 28. doi: 10.1016/j.intimp.2012.09.007..
Novel one-step immunoassays to quantify α-synuclein: applications for biomarker development and high-throughput screening
J Biol Chem.; DOI: 10.1074/jbc.M112.379792
Lowered Serum Amyloid-β1-42 Autoantibodies in Individuals with Lifetime Depression
Journal of Alzheimer’s Disease; 2012 Jul 5. DOI: 10.3233/JAD-2012-120625
Methamphetamine binds to α-synuclein and causes a conformational change which can be detected by nanopore analysis
FEBS Letters (2012), doi:10.1016/j.febslet.2012.06.040
A Novel “Molecular Tweezer” Inhibitor of α-Synuclein Neurotoxicity in Vitro and in Vivo.
Neurotherapeutics; Volume 9, Number 2, 464-476, DOI: 10.1007/s13311-012-0105-1.
New evidence on α-synuclein and Tau binding to conformation and sequence specific GC* rich DNA: Relevance to neurological disorders
J Pharm Bioallied Sci.; 2012 Apr-Jun; 4(2): 112–117. doi: 10.4103/0975-7406.9481; PMCID: PMC3341714
An antibody with high reactivity for disease-associated α-synuclein reveals extensive brain pathology
Acta Neuropathologica; 2012, DOI: 10.1007/s00401-012-0964-x.
α-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases
Journal of Neurochemistry; 120: 440–452. 2012 Feb; doi: 10.1111/j.1471-4159.2011.07576.x.
α-Synuclein potentiates interleukin-1β-induced CXCL10 expression in human A172 astrocytoma cells
Neuroscience Letters; Volume 507, Issue 2, 24 January 2012, Pages 133–136 DOI:10.1016/j.neulet.2011.12.001.
The acute inflammatory response to intranigral a-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation
J Neuroinflammation. 2011 Nov 28:8:166. doi: 10.1186/1742-2094-8-166.